By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel is generally bearish on Dauch (DCH), citing high execution risk, cyclical demand, and thin margins. They question the fund's conviction and the feasibility of the $100M synergy target.
Risk: Execution slippage in tariffs or demand, high integration costs, and cyclical auto demand.
Opportunity: Realization of $100M in annualized synergies by 2027 to flip the bottom line.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Cramer Rosenthal McGlynn bought 3,486,423 shares of Dauch Corporation; the estimated trade value was $24.25 million based on quarterly average pricing.
The quarter-end position value increased by $20.67 million, reflecting both share purchases and price movement.
The transaction represents 1.78% of the fund’s reportable AUM.
The quarter-end Dauch stake stood at 3,486,423 shares valued at $20.67 million.
Cramer Rosenthal McGlynn established a new position in Dauch Corporation (NYSE:DCH) during the first quarter, acquiring approximately 3,486,423 shares in a trade estimated at $24.25 million based on quarterly average pricing, according to a May 15, 2026, SEC filing.
According to a SEC filing dated May 15, 2026, Cramer Rosenthal McGlynn reported a new holding in Dauch Corporation, purchasing 3,486,423 shares. The estimated transaction value was $24.25 million, calculated using the average closing price for the quarter. At quarter-end, the position was valued at $20.67 million, reflecting both the purchase and subsequent price changes.
NASDAQ: EVRG: $34.97 million (2.6% of AUM)
As of Tuesday, shares of Dauch were priced at $5.78, up about 28% over the past year, compared to a 24% gain for the S&P 500.
| Metric | Value | |---|---| | Revenue (TTM) | $6.80 billion | | Net Income (TTM) | ($127.10 million) | | Price (as of market close 2026-05-14) | $5.78 |
Dauch Corporation is a leading supplier of driveline and metal forming technologies, serving a broad spectrum of automotive and industrial clients worldwide. The company leverages its engineering expertise and manufacturing scale to support both traditional and electric vehicle platforms. With a diversified product portfolio and a global footprint, Dauch Corporation is positioned to address evolving industry demands in mobility and vehicle electrification.
With this new position, Cramer Rosenthal McGlynn appears to be leaning into the idea that Dauch’s Dowlais acquisition, completed this February, could create a much larger and more profitable company over the next few years, even if near-term results remain messy.
The company’s latest quarterly report, released on May 8, showed both the opportunity and the risks. Sales jumped to $2.38 billion from $1.41 billion a year earlier, largely driven by the Dowlais acquisition, while adjusted EBITDA climbed to $308.5 million. Still, Dauch posted a net loss of $100.3 million as acquisition-related costs, restructuring expenses, and integration spending weighed on results.
Management is forecasting 2026 sales of as much as $10.8 billion and expects more than $100 million in annualized synergy benefits by the end of year one. The company also said it expects to mitigate most tariff-related costs. Going forward, integration will be important, but thus far, it seems that at least Cramer Rosenthal, a value-focused fund, sees opportunity.
Before you buy stock in Dauch, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dauch wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $483,476! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,362,941!
Now, it’s worth noting Stock Advisor’s total average return is 998% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 19, 2026. *
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Dauch's headline sales surge from the Dowlais deal conceals integration costs and margin pressure that a single value fund's modest position does not resolve."
Cramer Rosenthal McGlynn's new 3.5 million share stake in Dauch (DCH), valued at $20.67 million quarter-end, signals a value bet on the February Dowlais acquisition. Yet the May 8 earnings reveal a $100.3 million net loss from integration and restructuring costs even as sales hit $2.38 billion and adjusted EBITDA reached $308.5 million. Management's $10.8 billion 2026 sales target and $100 million synergy goal face execution hurdles plus tariff exposure. At $5.78, the stock's 28% yearly gain looks fragile given negative TTM net income of $127 million and the fund's small 1.78% AUM allocation.
The acquisition could deliver synergies ahead of schedule and convert the loss-making base into sustained free cash flow, validating the fund's timing before the broader market prices in the scale.
"The fund is betting on 2026-2027 synergy realization and margin recovery, but the $100M net loss despite strong EBITDA suggests integration is messier than the headline suggests, and execution risk is priced in only partially."
Dauch (DCH) is a classic turnaround-in-progress story, and Cramer Rosenthal's $24M entry is noteworthy—but the article buries the real tension. Yes, the Dowlais acquisition doubled revenue to $2.38B and promises $100M+ in synergies. But the company posted a $100M net loss in Q1 2026 despite $308.5M adjusted EBITDA. That's a 33% gap between adjusted and reported earnings—integration costs, restructuring, and tariff hedging are masking underlying profitability. At $5.78, DCH trades at ~0.9x TTM sales on a $6.8B revenue base, which looks cheap until you ask: when does that $100M loss flip to profit? The 28% YTD gain already prices in some optimism. The real risk: automotive suppliers are cyclical, tariff mitigation is speculative, and integration execution risk is real.
A $24M position from a value fund entering a stock already up 28% could signal late-stage momentum chasing rather than deep value; if integration stumbles or automotive demand softens, adjusted EBITDA won't save a company still burning cash on an absolute basis.
"The success of this position depends entirely on whether Dauch can convert its $10.8B revenue forecast into positive free cash flow before integration costs exhaust their liquidity."
Cramer Rosenthal McGlynn’s entry into Dauch (DCH) is a classic value-investor bet on synergy realization following the Dowlais acquisition. While the 1.78% AUM allocation suggests conviction, the market is currently pricing DCH at a steep discount due to the $127M TTM net loss. The bull case hinges on the $100M in annualized synergies materializing by 2027 to flip the bottom line. However, the automotive supply chain is notoriously capital-intensive and sensitive to cyclical downturns. With $6.8B in revenue but negative earnings, the margin for error during this integration is razor-thin. Investors are effectively buying a turnaround story that requires flawless execution in a high-interest-rate environment.
The integration of Dowlais could lead to 'diseconomies of scale' where restructuring costs balloon, further eroding cash flow and forcing Dauch to dilute shareholders to service its debt load.
"The bullish case hinges on Dowlais-driven synergies and aggressive integration success; without that, the upside thesis is risky."
CR McGlynn’s new DCH stake signals a belief that the Dowlais deal can unlock scale and profits, but the math is fragile: 3.486M shares bought around $24.25M; quarter-end value $20.67M indicates mark-to-market headwinds. The stock trades at $5.78, up 28% over a year, yet Dauch shows a negative net income on $6.8B TTM revenue, while guiding up to $10.8B in 2026 revenue with $100M+ in annualized synergies—dependent on aggressive integration and tariff mitigation. Risks include execution failure, higher integration costs, and cyclical auto demand. The article glosses over capital needs and margin trajectory, which could dampen the upside if synergies miss.
The Dowlais synergy story may be overstated and the near-term losses and integration risks could mean the stock is already pricing in optimistic outcomes; execution failure could trigger a multiple re-rate.
"Small AUM weighting plus immediate unrealized loss together signal weaker fund conviction than the synergy story requires."
ChatGPT flags the mark-to-market drop from $24.25M cost to $20.67M value, yet this pairs directly with Grok's 1.78% AUM slice to reveal shallow conviction. A value fund unwilling to size beyond token exposure after the 28% run-up implies the $100M synergy math must clear a high bar before any re-rating. Execution slippage in tariffs or demand would quickly expose that caution as justified.
"Position sizing alone doesn't reveal conviction; timing relative to the 28% gain and automotive cycle exposure does."
Grok's read of the 1.78% AUM allocation as 'shallow conviction' misses the mark. A $24M position for a multi-billion AUM fund entering a $6.8B revenue company post-acquisition is actually right-sized for a turnaround bet—not token. The real tell: CR McGlynn bought *after* the 28% run, which either signals they see deeper value than the market, or they're late to a momentum trade. The mark-to-market loss ($3.58M in weeks) is noise if synergies materialize; it's a warning flag if automotive demand rolls over Q3-Q4.
"The company's thin operating margins and potential debt-to-EBITDA strain make the 2027 synergy target a high-risk gamble rather than a value-based turnaround."
Claude and Grok are debating position sizing, but both ignore the balance sheet. A $100M loss on $2.38B quarterly revenue isn't just 'integration costs'; it implies a dangerously thin operating margin that leaves zero cushion for the cyclical auto downturn Gemini mentioned. If the debt-to-EBITDA ratio spikes during this integration, management won't have the luxury of waiting for 2027 synergies. This isn't a value play; it's a distressed leverage gamble masquerading as growth.
"The real risk is capex/working capital and debt service to fund a large revenue jump, not the mere existence of synergies."
Gemini's 'distressed leverage gamble' framing misses the real stress test: the capex and working capital needed to lift revenue from $6.8B to $10.8B, plus debt service in a cyclical auto environment. Even with $100M in annual synergies, the company must achieve meaningful EBITDA expansion; Q1 showed a $100M net loss on $2.38B revenue, and TTM net income is negative. Tariffs and integration costs keep liquidity risk high.
The panel is generally bearish on Dauch (DCH), citing high execution risk, cyclical demand, and thin margins. They question the fund's conviction and the feasibility of the $100M synergy target.
Realization of $100M in annualized synergies by 2027 to flip the bottom line.
Execution slippage in tariffs or demand, high integration costs, and cyclical auto demand.